Article: Altered NAD+ and Glutathione Metabolism in Fatty Liver Disease: Preclinical Findings

PrevNext
Liver Disease Liver Health Preclinical

Altered NAD+ and Glutathione Metabolism in Fatty Liver Disease: Preclinical Findings

Synopsis

In patients with non-alcoholic fatty liver disease (NAFLD), researchers identified altered liver metabolism, specifically increased demand for NAD+ and glutathione (GSH), a key antioxidant. Blood levels of amino acids involved in GSH synthesis (glycine, serine) were lower in those with more liver fat. Liver enzyme analysis confirmed impaired GSH production. Supplementing mice on a Western diet with NAD+ and GSH precursors prevented liver fat accumulation. In a small human study, serine supplementation improved liver function and reduced fat. This suggests restoring NAD+ and GSH metabolism through diet may treat NAFLD.

Journal

Molecular Systems Biology

Share

Read more

Metabolic Health

Nicotinamide Riboside Dose Improves Metabolic Flexibility: Preclinical Findings

SynopsisMetabolic flexibility—the ability to switch between burning carbs and fats—is a marker of metabolic health. To study NR's effect on this, mice on a mildly obese diet received varying NR dos...

Read more
COVID/Long-COVID

NAD+ Biosynthesis Enzyme Protects Aortic Smooth Muscle Cells: Preclinical Findings

Synopsis The walls of the aorta weaken with age and stress, risking serious damage. Smooth muscle cells (SMCs) in the aorta need NAD+, made by the enzyme NAMPT, for health. In humans with aortic d...

Read more